| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.4 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |